Evolva Holding SA (EVE) - Net Assets

Latest as of December 2025: CHF5.94 Million CHF ≈ $7.51 Million USD

Based on the latest financial reports, Evolva Holding SA (EVE) has net assets worth CHF5.94 Million CHF (≈ $7.51 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF6.76 Million ≈ $8.54 Million USD) and total liabilities (CHF812.70K ≈ $1.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Evolva Holding SA tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF5.94 Million
% of Total Assets 87.97%
Annual Growth Rate -14.32%
5-Year Change -95.49%
10-Year Change -96.57%
Growth Volatility 62.48

Evolva Holding SA - Net Assets Trend (2005–2025)

This chart illustrates how Evolva Holding SA's net assets have evolved over time, based on quarterly financial data. See EVE defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Evolva Holding SA (2005–2025)

The table below shows the annual net assets of Evolva Holding SA from 2005 to 2025. For live valuation and market cap data, see EVE company net worth.

Year Net Assets Change
2025-12-31 CHF5.94 Million
≈ $7.51 Million
-9.89%
2024-12-31 CHF6.60 Million
≈ $8.34 Million
+18.80%
2023-12-31 CHF5.55 Million
≈ $7.02 Million
-94.77%
2022-12-31 CHF106.24 Million
≈ $134.31 Million
-19.38%
2021-12-31 CHF131.77 Million
≈ $166.59 Million
-9.18%
2020-12-31 CHF145.09 Million
≈ $183.44 Million
-15.92%
2019-12-31 CHF172.56 Million
≈ $218.17 Million
-11.12%
2018-12-31 CHF194.16 Million
≈ $245.47 Million
-12.03%
2017-12-31 CHF220.72 Million
≈ $279.05 Million
+27.54%
2016-12-31 CHF173.06 Million
≈ $218.79 Million
-14.92%
2015-12-31 CHF203.42 Million
≈ $257.17 Million
+16.24%
2014-12-31 CHF174.99 Million
≈ $221.24 Million
+110.13%
2013-12-31 CHF83.28 Million
≈ $105.29 Million
+35.99%
2012-12-31 CHF61.24 Million
≈ $77.42 Million
-16.36%
2011-12-31 CHF73.22 Million
≈ $92.57 Million
+38.23%
2010-12-31 CHF52.97 Million
≈ $66.97 Million
-22.03%
2009-12-31 CHF67.93 Million
≈ $85.89 Million
+210.74%
2008-12-31 CHF21.86 Million
≈ $27.64 Million
-67.43%
2007-12-31 CHF67.12 Million
≈ $84.86 Million
+2.51%
2006-12-31 CHF65.48 Million
≈ $82.78 Million
-49.97%
2005-12-31 CHF130.88 Million
≈ $165.47 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Evolva Holding SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 36964992000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock CHF7.23 Million 121.65%
Other Comprehensive Income CHF45.07 Million 758.37%
Other Components CHF429.50 Million 7226.28%
Total Equity CHF5.94 Million 100.00%

Evolva Holding SA Competitors by Market Cap

The table below lists competitors of Evolva Holding SA ranked by their market capitalization.

Company Market Cap
SUPERNOVA METALS CORP.
F:A1S
$6.95 Million
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
$6.95 Million
Bt Brands Inc
NASDAQ:BTBD
$6.95 Million
SECUREKLOUD TECHNOLOGIES LIMITED
NSE:SECURKLOUD
$6.96 Million
Alta Zinc Limited
F:8EE
$6.95 Million
Vivos Therapeutics Inc
NASDAQ:VVOS
$6.95 Million
BlackRock Greater Europe Investment Trust plc
LSE:BRGE
$6.94 Million
FD Technologies Plc
LSE:FDP
$6.93 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Evolva Holding SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 6,596,300 to 5,943,600, a change of -652,700 (-9.9%).
  • Net loss of 652,700 reduced equity.
  • Other comprehensive income decreased equity by 99.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF-652.70K -10.98%
Other Comprehensive Income CHF-99.00 -0.0%
Other Changes CHF99.00 +0.0%
Total Change CHF- -9.89%

Book Value vs Market Value Analysis

This analysis compares Evolva Holding SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.90x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.00x to 1.90x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 CHF1774.36 CHF1.57 x
2006-12-31 CHF775.76 CHF1.57 x
2007-12-31 CHF699.51 CHF1.57 x
2008-12-31 CHF208.51 CHF1.57 x
2009-12-31 CHF199.03 CHF1.57 x
2010-12-31 CHF73.50 CHF1.57 x
2011-12-31 CHF89.47 CHF1.57 x
2012-12-31 CHF69.78 CHF1.57 x
2013-12-31 CHF70.03 CHF1.57 x
2014-12-31 CHF124.32 CHF1.57 x
2015-12-31 CHF119.65 CHF1.57 x
2016-12-31 CHF90.00 CHF1.57 x
2017-12-31 CHF114.47 CHF1.57 x
2018-12-31 CHF62.99 CHF1.57 x
2019-12-31 CHF56.00 CHF1.57 x
2020-12-31 CHF46.10 CHF1.57 x
2021-12-31 CHF37.44 CHF1.57 x
2022-12-31 CHF24.82 CHF1.57 x
2023-12-31 CHF1.03 CHF1.57 x
2024-12-31 CHF0.91 CHF1.57 x
2025-12-31 CHF0.82 CHF1.57 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Evolva Holding SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -10.98%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.14x
  • Recent ROE (-10.98%) is above the historical average (-118.01%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 -26.77% 0.00% 0.00x 1.04x CHF-48.13 Million
2006 -110.77% -26513.74% 0.00x 1.28x CHF-79.08 Million
2007 -88.08% -35937.03% 0.00x 1.29x CHF-65.83 Million
2008 -39.62% -2040.98% 0.01x 2.03x CHF-10.85 Million
2009 -14.22% -50.77% 0.20x 1.37x CHF-16.37 Million
2010 -44.88% -125.07% 0.25x 1.45x CHF-28.49 Million
2011 -30.89% -202.64% 0.10x 1.47x CHF-29.72 Million
2012 -26.13% -228.19% 0.08x 1.48x CHF-22.13 Million
2013 -19.49% -180.70% 0.08x 1.30x CHF-23.80 Million
2014 -12.33% -230.02% 0.04x 1.23x CHF-38.67 Million
2015 -15.82% -339.28% 0.04x 1.15x CHF-52.05 Million
2016 -21.02% -411.19% 0.04x 1.16x CHF-53.08 Million
2017 -17.66% -569.26% 0.03x 1.09x CHF-61.05 Million
2018 -15.05% -327.03% 0.04x 1.10x CHF-48.63 Million
2019 -12.54% -186.61% 0.06x 1.11x CHF-38.90 Million
2020 -20.59% -396.10% 0.05x 1.15x CHF-44.38 Million
2021 -31.32% -417.76% 0.06x 1.19x CHF-54.44 Million
2022 -40.82% -279.08% 0.12x 1.23x CHF-53.99 Million
2023 -1895.13% -1114.95% 0.96x 1.77x CHF-105.78 Million
2024 15.83% 0.00% 0.00x 1.14x CHF384.37K
2025 -10.98% 0.00% 0.00x 1.14x CHF-1.25 Million

Industry Comparison

This section compares Evolva Holding SA's net assets metrics with peer companies in the Shell Companies industry.

No peer company data available for comparison.

About Evolva Holding SA

SW:EVE Switzerland Shell Companies
Market Cap
$14.31 Million
CHF11.32 Million CHF
Market Cap Rank
#27880 Global
#212 in Switzerland
Share Price
CHF1.57
Change (1 day)
-4.27%
52-Week Range
CHF0.75 - CHF1.85
All Time High
CHF259.80
About

EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more